Aduro Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Aduro Biotech and buy or sell other stocks, ETFs, and their options commission-free!About ADRO
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes.
CEOStephen T. Isaacs
CEOStephen T. Isaacs
Employees—
Employees—
HeadquartersBerkeley, California
HeadquartersBerkeley, California
Founded2008
Founded2008
Employees—
Employees—
ADRO Key Statistics
Market cap2.90B
Market cap2.90B
Price-Earnings ratio-11.49
Price-Earnings ratio-11.49
Dividend yield—
Dividend yield—
Average volume1.98M
Average volume1.98M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$40.51
52 Week high$40.51
52 Week low$18.34
52 Week low$18.34
Stock Snapshot
With a market cap of 2.9B, Aduro Biotech(ADRO) trades at $14.60. The stock has a price-to-earnings ratio of -11.49.
Aduro Biotech(ADRO) stock opened on 2025-12-19 at —. The price climbed to — and dipped to —.
Aduro Biotech(ADRO) shares are trading with a volume of 0, against a daily average of 1.98M.
In the last year, Aduro Biotech(ADRO) shares hit a 52-week high of $40.51 and a 52-week low of $18.34.
In the last year, Aduro Biotech(ADRO) shares hit a 52-week high of $40.51 and a 52-week low of $18.34.
People also own
Based on the portfolios of people who own ADRO. This list is generated using Robinhood data, and it’s not a recommendation.